Financial reports
10-Q
2024 Q1
Quarterly report
15 May 24
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
17 May 22
Current reports
8-K
Departure of Directors or Certain Officers
3 Jun 24
8-K
American Oncology Network Announces Voluntary Delisting From Nasdaq
21 May 24
8-K
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
15 May 24
8-K
Departure of Directors or Certain Officers
3 May 24
8-K
Departure of Directors or Certain Officers
22 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results
28 Mar 24
8-K
Index to Financial Statements
27 Nov 23
8-K
American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results
14 Nov 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
Registration and prospectus
424B3
Prospectus supplement
3 Jun 24
25
Voluntary exchange delisting
31 May 24
424B3
Prospectus supplement
21 May 24
424B3
Prospectus supplement
16 May 24
424B3
Prospectus supplement
6 May 24
POS AM
Prospectus update (post-effective amendment)
29 Apr 24
424B5
Prospectus supplement for primary offering
7 Dec 23
S-8
Registration of securities for employees
27 Nov 23
S-1/A
IPO registration (amended)
17 Nov 23
S-1
IPO registration
13 Oct 23
Proxies
DEFA14A
Additional proxy soliciting materials
8 Mar 23
DEFA14A
Additional proxy soliciting materials
27 Feb 23
DEFA14A
Additional proxy soliciting materials
21 Feb 23
DEF 14A
Definitive proxy
9 Feb 23
DEFA14A
Additional proxy soliciting materials
6 Feb 23
PRER14A
Preliminary revised proxy
3 Feb 23
PRE 14A
Preliminary proxy
17 Jan 23
PREM14A
Preliminary proxy related to merger
6 Jan 23
DEFA14A
Additional proxy soliciting materials
6 Jan 23
DEF 14A
Definitive proxy
8 Nov 22
Other
EFFECT
Notice of effectiveness
6 May 24
EFFECT
Notice of effectiveness
7 Dec 23
CORRESP
Correspondence with SEC
4 Dec 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
3 Nov 23
SEC STAFF
SEC staff action: Order
31 Jul 23
EFFECT
Notice of effectiveness
19 Jul 23
CORRESP
Correspondence with SEC
14 Jul 23
CORRESP
Correspondence with SEC
12 Jul 23
SEC STAFF
SEC staff action: Order
10 Jul 23